Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

NIH Stops Stem Cell Heart Failure Trial Over Retracted Data

Stop sign

National Heart, Lung, and Blood Institute, or NHLBI, part of the National Institutes of Health is suspending a clinical trial of stem cells to regenerate new heart muscle. . . . → Read More: NIH Stops Stem Cell Heart Failure Trial Over Retracted Data

Gene Silencing Technology Licensed in $3.7B Deal

RNA strand illustration

Dicerna Pharmaceuticals, developing treatments for disease that silence genes by interfering with their RNA instructions, is licensing its technology to drug maker Eli Lilly and Co . . . → Read More: Gene Silencing Technology Licensed in $3.7B Deal

BASF Licensing Precise Crispr Editing from Broad Institute

Crispr-Cas9 illustration

The global chemical company BASF is licensing a more precise form of genome editing from the Broad Institute, a genetics research center affiliated with Harvard University and MIT. . . . → Read More: BASF Licensing Precise Crispr Editing from Broad Institute

Genome Editing, Informatics Lead to New Antibiotic

Antibiotics from engineered bacteria

Researchers in the U.K. created an antibiotic acid from a natural microbe found in soil, using a combination of the genome editing technique Crispr and bioinformatics. . . . → Read More: Genome Editing, Informatics Lead to New Antibiotic

Licensing Deal for Bioinks in 3-D Printed Transplant Lungs

Human lungs illustration

A company in Maryland developing alternatives to human organ transplants is licensing a technology to help create 3-D printed lungs for transplantation with bioinks derived from tobacco plants. . . . → Read More: Licensing Deal for Bioinks in 3-D Printed Transplant Lungs

Harvard Spin-Off, AbbVie Partner on Fibrosis Treatments

Handshake

Drug maker AbbVie and biotechnology company Morphic Therapeutic are collaborating on new treatments for fibrosis based on Morphic’s technology blocking proteins that promote fibrosis. . . . → Read More: Harvard Spin-Off, AbbVie Partner on Fibrosis Treatments

Antibody Designed to Stop Inflammation Protein in Brain

Katerina Akassoglou

A synthetic antibody is shown in tests with lab mice to block the blood protein fibrin from causing inflammation and related damage to brain cells found in neurodegenerative diseases. . . . → Read More: Antibody Designed to Stop Inflammation Protein in Brain

Model Biotech Materials Sharing Agreement Unveiled

Lab jars and beakers

A document with standard legal language for terms and conditions of sharing biotechnology materials is now available for academic and industry research labs. . . . → Read More: Model Biotech Materials Sharing Agreement Unveiled

Cancer Antibody Trials Stopped After Patient Death

Stop signs graphic

Two clinical trials testing synthetic antibodies designed to treat blood-related cancers were stopped by their developer after a participant in one trial died from adverse effects. . . . → Read More: Cancer Antibody Trials Stopped After Patient Death

Prenatal Genome Edits Prevent Inherited Liver Disorder

Editing DNA

Research with lab mice shows prenatal genome editing with techniques including Crispr can correct an inherited defect associated with a fatal congenital liver disorder. . . . → Read More: Prenatal Genome Edits Prevent Inherited Liver Disorder